ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.695
      -0.11%
      Bitcoin
      64,972.00
      -0.25%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. KALA BIO Inc (KALA)

      7. KALA BIO Inc (KALA) News

      KALA

      KALA BIO (KALA)

      KALA BIO Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KALA
      DateTimeSourceHeadlineSymbolCompany
      02/25/20214:03PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:KALAKALA BIO Inc
      02/25/20217:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      02/25/20217:00AMBusiness WireKala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      02/18/20218:00AMBusiness WireKala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference CallNASDAQ:KALAKALA BIO Inc
      02/17/20214:01PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      02/16/20217:00AMBusiness WireKala Pharmaceuticals Announces EYSUVIS™ Now Covered by Express ScriptsNASDAQ:KALAKALA BIO Inc
      02/12/20215:27PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KALAKALA BIO Inc
      02/12/20214:11PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KALAKALA BIO Inc
      02/02/20213:15PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KALAKALA BIO Inc
      01/20/20214:01PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      01/07/20217:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      01/07/20217:00AMBusiness WireKala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease & Provides Update on Developmen...NASDAQ:KALAKALA BIO Inc
      01/05/20214:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      01/05/20214:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      01/05/20214:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KALAKALA BIO Inc
      01/04/20218:00AMBusiness WireKala Pharmaceuticals to Present at Upcoming Investor Conferences in JanuaryNASDAQ:KALAKALA BIO Inc
      12/18/20204:01PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      11/18/20204:05PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      11/16/20207:00AMBusiness WireKala Pharmaceuticals Provides Update on Launch Plans for EYSUVISTM for the Treatment of Dry Eye DiseaseNASDAQ:KALAKALA BIO Inc
      11/11/20208:00AMBusiness WireKala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
      11/05/20204:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KALAKALA BIO Inc
      11/05/20207:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      11/05/20207:00AMBusiness WireKala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
      10/29/20208:00AMBusiness WireKala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference CallNASDAQ:KALAKALA BIO Inc
      10/27/20207:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      10/27/20207:00AMBusiness WireKala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs & Symptoms of Dry Eye Dis...NASDAQ:KALAKALA BIO Inc
      10/19/20204:05PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      09/18/20204:05PMBusiness WireKala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
      09/17/20207:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
      09/10/20208:00AMBusiness WireKala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™NASDAQ:KALAKALA BIO Inc
       Showing the most relevant articles for your search:NASDAQ:KALA